These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3455751

  • 1. Aclacinomycin A and behenoyl arabinofuranosylcytosine combination chemotherapy for previously untreated acute leukemia.
    Sampi K, Sakurai M, Kaneko Y, Hattori M.
    Oncology; 1986; 43(1):18-22. PubMed ID: 3455751
    [Abstract] [Full Text] [Related]

  • 2. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
    Sampi K, Honda T, Hayashi Y, Hattori M.
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
    [Abstract] [Full Text] [Related]

  • 3. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
    Ishige K, Takagi T, Oguro M.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
    [Abstract] [Full Text] [Related]

  • 4. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.
    Nagura E, Kimura K, Yamada K, Ohta K, Maekawa T, Takaku F, Uchino H, Masaoka T, Amaki I, Kawashima K.
    Cancer Chemother Pharmacol; 1994 Jul; 34(1):23-9. PubMed ID: 8174198
    [Abstract] [Full Text] [Related]

  • 5. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
    Park HS, Kim DW, Kim CC, Kim HK, Kim JS, Hwang TJ, Kim HJ, Kim HS, Song HS, Park JW, Ahn HS, Chung TJ, Cho KS, Lee KS, Choi YM.
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute non-lymphocytic leukemia in Saitama Cancer Center.
    Sampi K, Sakurai M, Kaneko Y, Hattori M.
    Anticancer Res; 1985 Oct; 5(3):293-6. PubMed ID: 4015043
    [Abstract] [Full Text] [Related]

  • 7. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
    Hansen OP, Pedersen-Bjergaard J, Ellegaard J, Brincker H, Boesen AM, Christensen BE, Drivsholm A, Hippe E, Jans H, Jensen KB.
    Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
    [Abstract] [Full Text] [Related]

  • 8. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
    Kawano F, Tajima H, Matsuoka Y, Asou N, Takatsuki K.
    Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
    [No Abstract] [Full Text] [Related]

  • 9. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP, Arlin ZA, Kempin SJ, Young CW.
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [Abstract] [Full Text] [Related]

  • 10. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].
    Takeyama H, Kataoka T, Yano K, Fukutani H, Watanabe E.
    Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186
    [No Abstract] [Full Text] [Related]

  • 11. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH, Lazarus HM, Wolff SN, Phillips GL, Herzig GP.
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [Abstract] [Full Text] [Related]

  • 12. [Adriamycin-aclacinomycin therapy (AA therapy) for acute leukemia unresponsive to BH-AC-DMP therapy].
    Kobayashi M, Tahara T.
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1473-9. PubMed ID: 6575727
    [Abstract] [Full Text] [Related]

  • 13. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I, Hara M, Ohmoto E, Oda Y, Endo Y, Fujimoto S, Uchida K, Takaoka K, Watanabe S, Lai M, Kohi F, Kitajima K, Kimura I, Sanada H, Tokioka M, Adachi T, Yorimitsu S.
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of acute myelogenous leukemia with concurrent administration of N4-behenoyl-ara-C, aclacinomycin A, 6-mercaptopurine and prednisolone].
    Ino T, Saito M, Matsui T, Shimizu S, Shigemura H, Nakamura K, Ono Y, Okamoto M, Takada T, Imura H.
    Rinsho Ketsueki; 1985 Feb; 26(2):139-46. PubMed ID: 3860668
    [No Abstract] [Full Text] [Related]

  • 15. Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.
    Takashima Y.
    J Clin Pharmacol; 1988 Apr; 28(4):356-62. PubMed ID: 3164731
    [Abstract] [Full Text] [Related]

  • 16. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
    Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Ribaud P, Schwarzenberg L.
    Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
    [Abstract] [Full Text] [Related]

  • 17. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A].
    Beck JD.
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845
    [Abstract] [Full Text] [Related]

  • 18. [Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group].
    Miyawaki S, Tanimoto M, Kobayashi T, Minami S, Tamura J, Omoto E, Kuriyama K, Hatake K, Saito K, Ohno R.
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1160-7. PubMed ID: 10945011
    [Abstract] [Full Text] [Related]

  • 19. Aclacinomycin-A in the induction treatment of childhood AML.
    Fink FM, Grümayer ER, Kardos G, Revesz T, Gadner H, Schuler D.
    Onkologie; 1986 Jun; 9(3):154-5. PubMed ID: 3528963
    [Abstract] [Full Text] [Related]

  • 20. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)].
    Shimazaki C, Nakajima Y, Ura Y, Hamami T, Haruyama H, Isemura T, Nakagawa M, Ijichi H.
    Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.